04:49 PM EDT, 04/25/2024 (MT Newswires) -- ResMed ( RMD ) reported fiscal Q3 non-GAAP earnings late Thursday of $2.13 per diluted share, up from $1.68 a year earlier.
Analysts surveyed by Capital IQ expected $1.91.
Revenue for the quarter ended March 31 was $1.20 billion, up from $1.12 billion a year earlier.
Analysts surveyed by Capital IQ expected $1.17 billion.
The board maintained the quarterly dividend at $0.48 per share, payable on June 13 to shareholders of record on May 9.
Shares of the company rose 9.6% in after-hours trading.
Price: 201.00, Change: +17.58, Percent Change: +9.58